Abstract
There are several lines of evidence from epidemiological as well as from laboratory experimental work linking human papillomaviruses (HPV) to the development of squamous cell cancer of the uterine cervix:
-
1.
The association of a sexually transmissible infectious agent is strongly suggested by epidemiological observations (for review, see Doll 1986)
-
2.
Cervical intraepithelial neoplasias (CIN), considered as putative precursor lesions of cervical cancer, are regularly associated with HPVs. Recently, the development of this kind of lesion was induced by infection of normal human epithelium in vitro and subsequent grafting into nude mice (Kreider et al. 1985). From such lesions papillomavirus particles can be purified which are efficient in a second round of infection. Thus the Koch’s postulate for a causal relationship of the infectious agent and the disease have been fulfilled.
-
3.
HPVs exhibit a transforming potential in vitro. Primary or established rodent cells can be transformed by transfection with the HPV early gene E7 (Bedell et al. 1987; Kanda et al. 1988; L. Laimins, personal communication), and a synergistic effect was observed with the activated human ras oncogene (Matlashewski et al. 1987). In addition, human keratinocytes, which represent the natural target cells for papillomavirus infection, are immortalized by HPV-16 or HPV-18 DNA, respectively (Drst et al. 1987; Pirisi et al. 1987; P. Kaur and J. McDougall, personal communication).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Androphy EJ, Lowy DR, Schiller JT (1987) A peptide encoded by the bovine papillomavirus E2 trans-activating gene binds to specific sites in papillomavirus DNA. Nature 325: 70–73
Baker CC, Phelbs WC, Lindgren V, Braun MJ, Gonda MA, Howley PM (1987) Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 61: 962–971
Bedell MA, Jones KH, Laimins LA (1987) The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat cells. J Virol 61: 3635–3640
Cripe TP, Haugen TH, Turk JP, Tabatabai F, Schmid PS, Dürst M, Gissmann L, Roman A, Turek LP (1987) Transcriptional regulation of the human papillomavirus-16 E6–E7 promoter by a keratinocyte dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis. EMBO J 12: 3745–3753
Dartmann K, Schwarz E, Gissmann L, zur Hausen H (1986) The nucleotide sequence and genome organization of human papillomavirus type 11. Virology 151: 124–130
Doll R (1986) Implications of epidemiological evidence for future progress. In: Peto R, zur Hausen H (eds) Viral etiology of cervical cancer, Banburry report 21. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 321–326
Dürst M, Dzarlieva-Petrusevska RT, Boukamp P, Fusenik N, Gissmann L (1987) Molecular and cytogenic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1: 251–256
Gissmann L, Dürst M, Oltersdorf T, von Knebel Doeberitz M (1987) Human papillomaviruses and cervical cancer. In: Steinberg BM, Bradsma JL, Taichman LB (eds) Cancer cells, vol 5. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 275–280
Gloss B, Bernard HU, Seedorf K, Klock G (1987) The upstream regulatory region of the human papillomavirus 16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J 6: 3735–3743
Haugen TH, Cripe TP, Ginder GD, Karin M, Turek LP (1987) Trans-activation of an upstream early gene promoter of bovine papillomavirus 1 by a product of the viral E2 gene. EMBO J 6: 145–152
Izant JG, Weintraub H (1985) Constitutive and conditional suppression of exogenous and endogeneous genes by anti-sense RNA. Science 229: 345–352
Kanda T, Furuno A, Yoshiike K (1988) Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J Virol 62: 610–613
Kreider JW, Howett MK, Wolfe SA, Bartlett GL, Zaino RJ, Sedlacek M, Mortel R (1985) Morphological transformation of human uterine cervix in vivo with papillomavirus from condylomata acuminata. Nature 317: 639–641
Matlashewski G, Schneider J, Banks L, Jones N, Murray A, Crawford L (1987) Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells. EMBO J 6: 1741–1746
Pirisi L, Yasumoto S, Feller M, Doninger J, diPaolo JA (1987) Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 61: 1061–1066
Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H (1985) Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314: 111–114
Smotkin D, Wettstein FO (1987) The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol 61: 1686–1689
Spalholz BA, Yang YC, Howley PM (1985) Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2-gene product. Cell 42: 183–191
Thierry F, Yaniv M (1987) The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV 18 regulatory protein. EMBO J 6: 3391–3397
von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L (1988) Modulation of human papillomavirus gene expression in C4–1 cervical carcinoma cells is correlated with altered growth properties. Cancer Res 38: (in press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Kleinheinz, A., von Knebel Doeberitz, M., Cripe, T.P., Turek, L.P., Gissmann, L. (1989). Human Papillomavirus Early Gene Products and Maintenance of the Transformed State of Cervical Cancer Cells in Vitro. In: Knippers, R., Levine, A.J. (eds) Transforming Proteins of DNA Tumor Viruses. Current Topics in Microbiology and Immunology, vol 144. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74578-2_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-74578-2_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74580-5
Online ISBN: 978-3-642-74578-2
eBook Packages: Springer Book Archive